Description

While there is a positive outlook for global in vitro diagnostics (IVD), top companies face challenges such as slowing growth, increasing competition, and a changing business environment. This market insight will analyze the current healthcare reality and effective strategies in 2014 and beyond. The study will examine high-growth IVD segments and the global competitive landscape. It will include a determination of the regions in which opportunities exist through 2020 and beyond. Global healthcare expenditures in key countries and regions will be presented. The market insight also will review external technology partners.